PA
JELD icon

PharVision Advisers’s JELD-WEN Holding JELD Stock Holding History

PharVision Advisers’s Portfolio JELD Stock Details JELD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-44,502
Closed -$219K – 850
2025
Q3 		$219K Buy
+44,502
New +$238K 0.12% 433
2025
Q1 		– Sell
-20,952
Closed -$172K – 398
2024
Q4 		$172K Buy
+20,952
New +$252K 0.15% 334

Other funds holding JELD

TCAM
Turtle Creek Asset Management Toronto, Ontario, Canada $2.67B AUM 0.64% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
MVP
Miller Value Partners Sarasota, Florida $383M AUM 38.57% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Jacobs Levy Equity Management
Jacobs Levy Equity Management Florham Park, New Jersey $23.8B AUM 25.4% 1-Year Est. Return

PharVision Advisers's JELD Position: Q4 2025 in Review

PharVision Advisers sold out of JELD-WEN Holding (JELD) in Q4 2025, closing a stake of 44,502 shares — an estimated $219K sold.

PharVision Advisers first reported a position in JELD in Q4 2024 and held it in 2 quarters. The position peaked at $219K in Q3 2025. 143 funds tracked by Wall St. Rank hold JELD as of Q4 2025.

  • PharVision Advisers reported no remaining JELD-WEN Holding position as of Q4 2025 after selling out during the quarter.
  • PharVision Advisers sold 44,502 JELD-WEN Holding shares in Q4 2025, an estimated $219K.
  • PharVision Advisers first reported a position in JELD-WEN Holding in Q4 2024 and held it in 2 quarters.
  • PharVision Advisers's JELD-WEN Holding position peaked at $219K in Q3 2025.
  • 143 funds tracked by Wall St. Rank held JELD-WEN Holding as of Q4 2025.

Based on PharVision Advisers's 13F filing for Q4 2025, filed 17 Feb 2026.